VALIDITY AND RELIABILITY STUDY

• Sponsor: T.C. ORDU ÜNİVERSİTESİ (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT05017506
• Collaborator: (none)
• Enrollment: 500
• Location: 1
• Anticipated Duration (Months): 6.6
• Patients Per Site Per Month: 75.7

Study Details

Study Description

Brief Summary

This research; The Turkish validity and reliability study of the "Coronavirus Impact Scale" developed by Stoddard and Kaufman (2020) will be conducted in order to bring a new measurement tool to our country.

Method: This research was planned as a methodological study. Research Question: Is the "Coronavirus Impact Scale" a valid and reliable measurement tool for Turkish society?

Condition or Disease	Intervention/Treatment	Phase
TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE	Other: A survey will be made.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 500 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE
• Anticipated Study Start Date: Sep 1, 2021
• Anticipated Primary Completion Date: Jan 1, 2022
• Anticipated Study Completion Date: Mar 21, 2022

Outcome Measures

Primary Outcome Measures

1. Coronavirus Impact Scale [8 months]

   The Coronovirus Impact Scale was developed by Stoddard and Kaufman (2020) to assess the impact of Covid-19 on people. The scale consists of 12 questions. Questions 1-9 in the scale are in 4-point Likert type, 0. There is no change, 1. Mild, 2. Moderate and 3. Severe, and points are taken between 0-3 from these questions. The questions between 10 and 11 on the scale are in a 5-point Likert type and are scored between 0-4 (indicating that from mild symptoms to death). However, the number of first degree family members diagnosed with coronavirus in question 10 and the number of relatives or close friends diagnosed with coronavirus in question 11 are not taken into account in the scale. The 12th question of the scale is open-ended and determines the other aspects that the coronavirus epidemic affects life. A minimum score of 0 and a maximum score of 35 are obtained from the scale, and as the score increases, the degree of exposure of people to the Corona virus increases.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• At least 18 years old,

• At least primary school graduate,

• Able to communicate verbally and

• Persons who agree to participate in the research will be included in the research.

Exclusion Criteria:

• Psychiatric illness and unable to communicate,

• Having a language problem

• Persons who do not have the skills to read and understand the questionnaire will be excluded from the research.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Ordu Univercity	Ordu	Cumhurıyet Campus	Turkey	52000

Sponsors and Collaborators

• T.C. ORDU ÜNİVERSİTESİ

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

• Stoddard J, Kaufman J. (2020). Coronavirus Impact Scale.

Publications

None provided.

• Responsible Party: Hacer Gok Ugur, Assoc. Dr., T.C. ORDU ÜNİVERSİTESİ
• ClinicalTrials.gov Identifier: NCT05017506
• Other Study ID Numbers: ayyuzlum3207*
• First Posted: Aug 24, 2021
• Last Update Posted: Sep 10, 2021
• Last Verified: Sep 1, 2021

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Hacer Gok Ugur, Assoc. Dr., T.C. ORDU ÜNİVERSİTESİ: Coronovirus, Impact, Reliability, Validity, Measuring tool, Nursing.
• Additional relevant MeSH terms: Coronavirus Infections

Study Results

No Results Posted as of Sep 10, 2021